Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing

Fig. 2

Treatment outcomes in each study arm indicating the potential impact of LAM in TB culture positive patients. a Smear-microscopy b clinic-based Xpert MTB/RIF testing. ‘False-positives’: These indicate patients that were sputum culture-negative, smear or Xpert MTB/RIF-negative and not given empiric TB treatment by the attending clinician that would have been LAM positive. These patients would have thus received inappropriate anti-TB treatment

Back to article page